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ABSTRACT 
 Over time, “superbugs,” or bacteria that have become resistant to antibiotics, have 
become a great concern in modern medicine. Viable alternates are currently being looked into as 
effective and safe ways to prevent or treat infections caused by these superbugs. One such 
method is through the utilization of the second messenger molecule cyclic-di-GMP (c-di-GMP) 
that has been shown to regulate phenotypes within other bacteria that may control surface 
colonization in Acinetobacter baumannii. Through a series of experiments, the active enzymes 
that create c-di-GMP - diguanylate cyclases - and break down c-di- GMP - phosphodiesterases  - 
have been inactivated in mutants to test phenotypes including biofilm formation, motility, 
antibiotic resistance, and desiccation survival. The research’s objective is to show that 
manipulation of c-di-GMP within the multi-drug resistant strain of Acinetobacter baumannii may 
serve as a means to control this bacteria.  
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INTRODUCTION 
Discovery of cyclic-di-GMP: 
 Cellulose, or poly-b-D-glucose is one of the most abundant biopolymers found across 
the world [8]. Most people already know that cellulose is found in plants; however, it has been 
found that some bacteria may also be capable of producing this biopolymer. The enzyme 
cellulose synthase, the enzyme responsible for cellulose synthesis, may have originated from 
cyanobacteria that has been postulated to form the symbiotic relationships with plants and is now 
the organelle chloroplast. Studies conducted by Manfred Aschner and Shlomo Hestrin at the 
Hebrew University of Jerusalem looked into the production of pure microcrystalline cellulose 
fibers from Komagataeibacter xylinus, an alpha-proteobacteria. Isolation of the cellulose 
synthase enzyme was attempted, but was determined that the enzyme required membrane-bound 
and soluble components to become active. Benziman and his colleagues were in search of the 
conditions that would activate cellulose synthase. It was his group that found that a Guanosine 
Triphosphate analog, guanosine 5’-[gamma-thio]triphosphate], was an effective stimulator to this 
enzyme. This was their key that lead them to be able to solubilize active cellulose synthase 
complexes that compared catalytically to a whole cell form. Once this was found, they set out to 
determine the structure of the activating factor. They had prior knowledge that it was a cyclic 
structure with a 3’ to 5’ bond. They soon found this molecule to be c-di-GMP as the activator 
factor. Benziman soon went on to find the GGDEF and EAL domains, which are diguanylate 
cyclases and phosphodiesterases involved in c-di-GMP turnover. These domains, along with 
curli fimbriae, played a key role in biofilm formation in other bacterial species such as 
Salmonella Typhimurium, Escherichia coli, Citrobacter, Enterobacter, and Klebsiella genera.  
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Mechanisms of cyclic di-GMP regulation: 
Since Benziman’s work, it has become more apparent that c-di-GMP plays a crucial role 
in the bacterial life cycle, as well as the virulence properties they possess that allow them to 
persist in today’s world [8]. In addition, this signaling molecule is rudimentary to other important 
pathways such as quorum sensing and phosphorylation pathways. C-di-GMP consists of two 
GMP moieties bound by a 5’-3’ cyclic ring and is one of the most well understood and 
researched cyclic dinucleotides. C-di-GMP levels within bacteria are controlled by both internal 
and environmental cues. This control is provided by the activity of two enzymes within the 
bacterium. These enzymes, diguanylate cyclases (DGCs) and c-di-GMP-specific 
phosphodiesterases (PDEs), can be found in all of the major bacterial phyla showing its 
prevalence as signaling proteins in the bacterial kingdom. The GGDEF domains of the DGCs 
arrange with one GTP, and dimerization allows them to perform condensation to create the c-di-
GMP molecule. The EAL domain, which relates to the PDEs, is responsible for the hydrolysis of 
c-di-GMP to yield a linear pGpG molecule that is eventually broken down to two GMPs. 
Dimerization of these proteins are orchestrated by the N-terminal sensory domains. This would 
explain why so many different proteins are present within the genome.  
C-di-GMP generates phenotypic changes through interaction with c-di-GMP-binding 
effectors that include transcriptional regulators, mRNA riboswitches, proteins that contain either 
GGDEF or EAL non-enzymatic domains, and proteins that contain a PilZ domain. Phenotypes 
regulated by c-di-GMP vary among bacterial species, but the motile-sessile transition and 
biofilm formation is a broadly conserved feature of c-di-GMP. Typically, it is shown that low 
levels of c-di-GMP are associated with motility, while the reverse can be said for biofilm 
formation and production. However, this system does not simply work as a “on/off” switch 
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within the bacteria. Motility and biofilm formation are regulated through various mechanisms 
depending on the bacteria of study. For instance, in E. coli and Salmonella Typhimurium 
increased levels of c-di-GMP interferes with both rotor-stator interface and the c-di-GMP-
binding flagellar brake YcgR. Motile conditions activate PDEs to increase their affinity to c-di-
GMP, permitting degradation and allowing effectors to increase motility. In terms of biofilm 
formation, bacteria can change their behavior when in contact with a surface. They begin 
exposing adhesins and producing an extracellular matrix to protect themselves. This behavior 
can be controlled by c-di-GMP at various levels within the cell. In addition, it is important to 
note that the gammaproteobacterial relative of Acinetobacter baumannii, Pseudomonas 
aeruginosa, exhibits isolates from human patients with cystic fibrosis showing mutations that 
lead to the upregulations of DGCs [8,10]. The use of second messenger molecules is a pretty 
straightforward system when compared to the protein-protein interactions that take places in a 
cell [8]. It is also easy, from an evolutionary standpoint, to incorporate changes into that system. 
While research on how c-di-GMP is incorporated  into other pathways such as quorum sensing 
and phosphorylation continues, overlap of these systems suggests a broad role for c-di-GMP in 
bacterial signaling. Several bacterial virulence factors have been shown to be tied to c-di-GMP 
levels, indicating that modulation of c-di-GMP levels may show promise in possible future 
treatments of patients.  
Acinetobacter baumannii: 
 Acinetobacter baumannii is a Gram-negative bacillus [1]. It is an anaerobic, non-
flagellated organism that is typically found within water and the soil. Due to the introduction of 
the notorious antibiotic penicillin by Alexander Fleming, people began treating everything with 
penicillin [6]. However, due to the over use of antibiotics throughout time since its discovery, it 
  
DEAL, JUSTIN COLLIER 9 
 
has expedited the process in which bacteria handle medications. Acinetobacter baumannii has 
developed tactics such as porins, b-lactamase, modifications of aminoglycosides, upregulation of 
efflux pumps, and so much more in order to protect itself from antibiotics [10]. Today, A. 
baumannii is also a common nosocomial infection that produces resilient biofilms on many 
surfaces within hospitals [1]. Biofilm formation can take place on ventilators and catheters. 
Immunocompromised people and those with open wounds from surgery can be at serious risk if 
infected with this opportunistic, multi-drug resistant pathogen. Due to its virulence properties, it 
can persist and survive in a hospital environment despite the sterilization methods that take place 
to combat this pathogen. In addition, Acinetobacter has been nicknamed the “Iraqibacter” due to 
its infection of United States Military members in Iraq and Afghanistan. Due to strains of this 
organism developing multi-drug resistance, having the ability to effectively produce biofilms 
within hospital environments, and be an opportunistic pathogen, controlling the second 
messenger molecule cyclic di-GMP in order to control the virulence factors in Acinetobacter 
baumannii can be a new way to prevent nosocomial infections within the human population.  
BACKGROUND 
The mutants and their domains: 
 Previous work has been done with c-di-GMP and Acinetobacter baumannii. Moriah 
Arnold, Dr. Erik Petersen, and their colleagues have done a series of experiments with a multi-
drug resistant clinical isolate (UW5075). They worked with transposon mutants deleted for each 
of the DGC- or PDE-encoding genes. Below, Figure 1 shows the mutants that correspond with 
diguanylate cyclase mutants. 
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Figure 1: Diguanylate cyclase only proteins within Acinetobacter baumannii. Blue bars indicate transmembrane 
domains. PAC domains are sensory domain components. 
 In theory, knocking these GGDEF protein domains out will limit the production of c-di-
GMP. However, some proteins contain both a GGDEF and an EAL domain. These both possess 
DGC and PDE activity regulated by their sensory domains.  
 
Figure 2: Dual DCG and PDE domains within A. baumannii proteins. PAS domains are sensory domains. 
 In continuation, we come to two strains with degenerate domains. In these cases, the 
active site residues within the protein have been mutated, but these domains may retain the 
ability to bind c-di-GMP or act in some other regulatory role. While both appear to contain both 
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GGDEF and EAL domains, in 1221 the EAL domain is predicted to be active but the GGDEF 
domain may be inactive due to mutations within the active site. Further, 1138 is inactive at its 
EAL domain and it is questionable if a GGDEF domain is even present.  
 
Figure 3: A. baumannii proteins containing degenerate enzymatic domains. 
 Lastly, the 2255 mutant, as shown in figure 4, does not have a DGC or PDE domain but 
instead has a PilZ domain. As mentioned before, PilZ is a c-di-GMP-binding domain and is 
responsible for type IV pili motility in other organisms.  
 
Figure 4: PilZ domain.  
 Figures 1-4 are used for a better understanding of which phenotypes will be expected of 
each mutant.  
Biofilm assay: 
 For the biofilm assay, cell cultures were diluted to an 0.05 optical density in lysogeny 
broth [3,11]. 200 microliters were then placed in a 96 well plate and grown overnight without 
shaking. They form a barrier along the interface of the water and air to adhere to the plastic. 
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Excess culture was removed and washed. Crystal violet was used to stain. After additional 
washing to remove the crystal violet stain, 100% ethanol was added to dissolve the crystal violet 
and mixed well. Then the intensity of the crystal violet was measured at 590 nanometers and 
converted in terms of the wild type. As shown in the figure below, our mutants who showed 
statistical significance were 0137, 1221, and 3354 and had lower levels of biofilm formation. In 
this case, it is most likely that their protein domains are behaving has DGCs. If this is the case, 




Figure 5: Relative biofilm formation of the A. baumannii mutants.  
Twitching Motility: 
 An agar plate was made with a higher water to agar ratio to allow a more liquified plate 
[3,11]. Then one microliter of 1.0 OD600 cell culture was stabbed in the center of the plate and 
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incubated at 37oC. A. baumannii is able to twitch along the lower surface of the agar at the 
plastic interface, generating a circular zone. Distance was then measured in centimeters and put 
in terms to the wild type.  
 
Figure 6: Twitching Motility Plates  
 The above figure shows that mutants 1221 and 2255 showed severe decrease in motility. 
In the case of 1221, the protein domain must be acting as a PDE since it is categorized as a dual 
or only EAL domain. 2255 is the PilZ domain which would conclude why motility decreases.  
Rifampicin Assay:  
 The next assay is determination of the minimum inhibitory concentration (MIC) [3,11]. 
Very few antibiotics are effective due to this being the hospital isolate strain. However, some 
mutants showed increased resistance to rifampicin, including 0137. Overnight cultures were 
diluted to 0.05 OD600 and were grown overnight in a 96 well plates. Eleven different two-fold 
dilutions of rifampicin took place while a twelfth one had no antibiotic. Measurements of relative 
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optical density compared to the non-treated well was how results was recorded. It was shown 
that the mutant 0137 grew better with rifampicin when compared to the wild type.  
 
Figure 7: MIC of Rifampicin  
MATERIALS AND METHODS 
Collection of domain images: 
 The visual images collected above (Figure 1-4) for the different domains of the mutant 
knockouts was compiled through use of the Prokaryotic Genome Analysis Tool (PGAT) and the 
protein database of Simple Modular Architecture Research Tool (SMART) websites [12,13]. 
Mutants’ identification credentials were used on PGAT in order to find the protein sequence. 
Once the protein sequence was retrieved, it was put into the SMART protein database in order to 
produce the visual aids.  
Desiccation Assay: 
 The desiccation assay was performed in a similar outline laid out by Biswas and Rather 
[3]. Frozen cultures of the Acinetobacter baumannii mutants were collected and streaked for 
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isolation onto lysogeny broth plates. Overnight growth cell culture was collected and washed in 
one milliliter of water three times by centrifugation. Cultures were then place into cuvettes, 
optical density measured at 600 nm, and samples were diluted to 1.0 optical density. From there, 
10 microliters of each sample was placed into their respective wells on a 96 well plate in 
triplicate. The 96 well plate was then incubated at 37o Celsius until the water had evaporated, 
then plates were transferred to 25°C. After two days, samples were resuspended in 200 
microliters of lysogeny broth through a well plate shaker. From there, fivefold dilutions took 
place in neighboring wells that contained phosphate-buffered saline. Once dilutions were 
completed, seven microliter droplets were collected from the dilutions and transferred onto dried 
petri dishes. The plates were allowed to sit at room temperature and colonies were allowed to 
grow at 37oC until countable. Colonies were then counted and recorded as shown in the results 
section. This was done on both inoculum samples as well as day 2 samples.  
RESULTS 
 Once the data was collected, it came to light that some of the mutants were not properly 
diluted on the inoculum day as planned in the materials and methods section. Therefore, final 
values were not adjusted to this inoculum count. The raw colony-forming unit per milliliter 
values were calculated for each particular mutant. They were then converted into a Log10 and put 
through the ANOVA test to determine statistical significance. Everything was then converted to 
the relevance of the wild type whose survival rate was set to 100% in order to compare the 
mutants’ survival to what was expected of the wild type data. Our negative control Escherichia 
coli wild type is also present within the graph (Figure 8).  
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Figure 8: Percent Relative Survival where E. coli wild type is used as a negative control. A baumannii mutants 




 Mutant 2255 has shown significance in both the desiccation assay as well as the motility 
assay. This can be speculated that by hindering motility survivability decreases under 
desiccation. This could be a failure to sense a surface, failure to adhere to the plastic, or send 
signals to stimulate the pilus interaction needed. This can even be extended to 1221 since it also 
showed a phenotypic change within the twitching motility assay. However, 1221 shows 
increased survivability. In the case of 2135, it can be hypothesized that deleting this gene, which 
is a diguanylate cyclase domain, can decrease concentration of cyclic di-GMP. By decreasing the 
concentration of this second messenger molecule, survivability under desiccation increases. As 
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seen before, knocking out the genes within 3354 not only increases survivability, but it also 
decreased the amount of biofilm A. baumannii produced. 3354 and 1221 are interesting mutants 
to show significance because they show to have both a diguanylate cyclase and the 
phosphodiesterase protein domains. 1221 one and 3354 shows increased survivability. This can 
be argued that in this instance they act as DGCs. This can be a complicated matter and leads us 
to the future steps of the experiment. 
For the future: 
 It is clear from this series of results that more research needs to be done to completely 
understand the role of cyclic di-GMP in Acinetobacter baumannii. An additional test that can be 
done with the multi-drug resistant strain 5075 is to perform an assay that accounts for 
concentrations of cyclic di-GMP within the cell. Mutants of 3354 and 1221 would need 
mutations in one of the active site domains at a time to determine which domain is responsible 
for motility, biofilm formation, and increased survivability in the desiccation assay. In 
continuation, complementation tests of the biofilm, twitching motility, antibiotic resistance, and 
desiccation assays will need to be conducted to ensure that deletion of these genes is responsible 
for the phenotypes. Further, direct measurement of concentrations of cyclic di-GMP need to 
performed, and these assays can be replicated in a second strain of A. baumannii to determine 
whether these phenotypes are conserved within other Acinetobacter strains. By designing these 
mutants and performing the series of experiments laid out, a more cohesive answer will emerge 
on how these different genes play a role in virulence.  
CONCLUSION 
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 Acinetobacter baumannii is a multi-drug resist bacterium that is responsible for 
nosocomial infections in patients by residing on plastics and hard surfaces through biofilms. The 
rising risk of superbugs that have grown resistance to an array of antibiotics is a growing concern 
in modern day medicine. It has been shown that the second messenger molecule, cyclic di-GMP, 
can control virulence factors, such as biofilm formation. The experimentation that has been done 
so far has shown that cyclic di-GMP does show means of controlling virulence factors within 
Acinetobacter baumannii. This shows promise in combating this multi-drug resistant bacterium 
and needs further research to be more conclusive on the exact mechanisms that are taking place.  
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